152 related articles for article (PubMed ID: 8895755)
1. MDR1 substrates/modulators protect against beta-estradiol-17beta-D-glucuronide cholestasis in rat liver.
Liu Y; Huang L; Hoffman T; Gosland M; Vore M
Cancer Res; 1996 Nov; 56(21):4992-7. PubMed ID: 8895755
[TBL] [Abstract][Full Text] [Related]
2. Adenosine triphosphate-dependent transport of estradiol-17beta(beta-D-glucuronide) in membrane vesicles by MDR1 expressed in insect cells.
Huang L; Hoffman T; Vore M
Hepatology; 1998 Nov; 28(5):1371-7. PubMed ID: 9794924
[TBL] [Abstract][Full Text] [Related]
3. Biliary secretion of glutathione in estradiol 17beta-D-glucuronide-induced cholestasis.
Mottino AD; Veggi LM; Wood M; Román JM; Vore M
J Pharmacol Exp Ther; 2003 Oct; 307(1):306-13. PubMed ID: 12893835
[TBL] [Abstract][Full Text] [Related]
4. Binding of 3H-estradiol-17 beta-(beta-D-glucuronide), a cholestatic organic anion, to rat liver plasma membranes. Evidence consonant with identification of organic anion carriers.
Takacs AL; Vore M
Mol Pharmacol; 1987 Oct; 32(4):511-8. PubMed ID: 3670282
[TBL] [Abstract][Full Text] [Related]
5. Multiple carriers for uptake of [3H]estradiol-17 beta(beta-D-glucuronide) in isolated rat hepatocytes.
Brouwer KL; Durham S; Vore M
Mol Pharmacol; 1987 Oct; 32(4):519-23. PubMed ID: 3670283
[TBL] [Abstract][Full Text] [Related]
6. Biliary excretion of estradiol-17 beta-glucuronide in the rat.
Takikawa H; Yamazaki R; Sano N; Yamanaka M
Hepatology; 1996 Mar; 23(3):607-13. PubMed ID: 8617443
[TBL] [Abstract][Full Text] [Related]
7. Mrp2 is essential for estradiol-17beta(beta-D-glucuronide)-induced cholestasis in rats.
Huang L; Smit JW; Meijer DK; Vore M
Hepatology; 2000 Jul; 32(1):66-72. PubMed ID: 10869290
[TBL] [Abstract][Full Text] [Related]
8. Ca(2+)-dependent protein kinase C isoforms are critical to estradiol 17beta-D-glucuronide-induced cholestasis in the rat.
Crocenzi FA; Sánchez Pozzi EJ; Ruiz ML; Zucchetti AE; Roma MG; Mottino AD; Vore M
Hepatology; 2008 Dec; 48(6):1885-95. PubMed ID: 18972403
[TBL] [Abstract][Full Text] [Related]
9. Altered localization and activity of canalicular Mrp2 in estradiol-17beta-D-glucuronide-induced cholestasis.
Mottino AD; Cao J; Veggi LM; Crocenzi F; Roma MG; Vore M
Hepatology; 2002 Jun; 35(6):1409-19. PubMed ID: 12029626
[TBL] [Abstract][Full Text] [Related]
10. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
[TBL] [Abstract][Full Text] [Related]
11. Role of microtubules in estradiol-17beta-D-glucuronide-induced alteration of canalicular Mrp2 localization and activity.
Mottino AD; Crocenzi FA; Pozzi EJ; Veggi LM; Roma MG; Vore M
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G327-36. PubMed ID: 15374814
[TBL] [Abstract][Full Text] [Related]
12. Taurocholate and steroid glucuronides: mutual protection against cholestasis in the isolated perfused rat liver.
Durham S; Vore M
J Pharmacol Exp Ther; 1986 May; 237(2):490-5. PubMed ID: 3701641
[TBL] [Abstract][Full Text] [Related]
13. Phosphoinositide 3-kinase/protein kinase B signaling pathway is involved in estradiol 17β-D-glucuronide-induced cholestasis: complementarity with classical protein kinase C.
Boaglio AC; Zucchetti AE; Sánchez Pozzi EJ; Pellegrino JM; Ochoa JE; Mottino AD; Vore M; Crocenzi FA; Roma MG
Hepatology; 2010 Oct; 52(4):1465-76. PubMed ID: 20815017
[TBL] [Abstract][Full Text] [Related]
14. Cholestasis induced by estradiol-17 beta-D-glucuronide: mechanisms and prevention by sodium taurocholate.
Adinolfi LE; Utili R; Gaeta GB; Abernathy CO; Zimmerman HJ
Hepatology; 1984; 4(1):30-7. PubMed ID: 6229465
[TBL] [Abstract][Full Text] [Related]
15. Increased estrogen sulfation of estradiol 17beta-D-glucuronide in metastatic tumor rat livers.
Sun H; Liu L; Pang KS
J Pharmacol Exp Ther; 2006 Nov; 319(2):818-31. PubMed ID: 16895976
[TBL] [Abstract][Full Text] [Related]
16. Hepatotoxic effects of estradiol-17 beta-D-glucuronide in the rat and monkey.
Slikker W; Vore M; Bailey JR; Meyers M; Montgomery C
J Pharmacol Exp Ther; 1983 Apr; 225(1):138-43. PubMed ID: 6300372
[TBL] [Abstract][Full Text] [Related]
17. Improvement of estradiol 17 beta-D-glucuronide cholestasis by intravenous administration of dimethylethanolamine in the rat.
Alvaro D; Angelico M; Cantafora A; Gaudio E; Gandin C; Santini MT; Masella R; Capocaccia L
Hepatology; 1991 Jun; 13(6):1158-72. PubMed ID: 1646761
[TBL] [Abstract][Full Text] [Related]
18. Bile duct obstruction is not a prerequisite for type I biliary epithelial cell hyperplasia.
Kossor DC; Meunier PC; Dulik DM; Leonard TB; Goldstein RS
Toxicol Appl Pharmacol; 1998 Oct; 152(2):327-38. PubMed ID: 9853002
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance p-glycoprotein 2 is essential for the biliary excretion of indocyanine green.
Huang L; Vore M
Drug Metab Dispos; 2001 May; 29(5):634-7. PubMed ID: 11302927
[TBL] [Abstract][Full Text] [Related]
20. Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts.
Utili R; Tripodi MF; Adinolfi LE; Gaeta GB; Abernathy CO; Zimmerman HJ
Hepatology; 1990 May; 11(5):735-42. PubMed ID: 2347547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
